Results 131 to 140 of about 186,195 (263)

Predictors of systemic sclerosis patients with interstitial lung disease progression: A retrospective study

open access: yesRheumatology &Autoimmunity, EarlyView.
The final systemic sclerosis patients with interstitial lung disease (SSc‐ILD) progression prediction model was composed of 6 significant risk factors: male, type 2 diabetes mellitus, pericardial effusion, anti‐Ro52, hypoproteinemia, and elevated C‐reactive protein. Our model demonstrated excellent prognostic utility.
Xi Cao   +6 more
wiley   +1 more source

Mitochondrial dynamics in autoimmune diseases

open access: yesRheumatology &Autoimmunity, EarlyView.
Roles of mitochondrial dynamic imbalance in autoimmune diseases. The imbalance of mitochondrial fusion and fission is involved in the occurrence and development of autoimmune diseases, including systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, type 1 diabetes, psoriasis, and autoimmune ...
Ruicong Ma   +5 more
wiley   +1 more source

Near‐Infrared Fluorescent Single‐Walled Carbon Nanotubes for Biosensing

open access: yesSmall, EarlyView.
Near‐infrared fluorescent single‐walled carbon nanotubes (SWCNTs) stand out as versatile biosensors due to their spectral overlap with the biological transparency window, surface‐sensitive fluorescence emission, and chemical modularity. This review offers a concise guide to understanding the photophysics of SWCNTs, various functionalization strategies,
Srestha Basu, Gili Bisker
wiley   +1 more source

Chronic Kidney Disease Increases Risk of Delayed Post‐Polypectomy Bleeding: A Large‐Scale Propensity Score‐Matched Analysis

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background The association between delayed post‐polypectomy bleeding and chronic kidney disease remains unclear. Objective This study investigated whether patients with chronic kidney disease are at an increased risk of delayed post‐polypectomy bleeding.
Hye Kyung Hyun   +12 more
wiley   +1 more source

The effectiveness and safety of azvudine treatment in COVID‐19 patients with kidney disease based on a multicenter retrospective cohort study

open access: yesVIEW, EarlyView.
A retrospective, multicenter cohort study was conducted across nine hospitals in Henan Province, aiming to evaluate the efficacy and safety of azvudine in hospitalized COVID‐19 patients with kidney disease. Through the application of Kaplan‒Meier and multivariate Cox regression analyses, it was found that azvudine may have potential effects in reducing
Bo Yu   +13 more
wiley   +1 more source

From clinical observations to molecular insights: Decoding immune checkpoint inhibitors‐induced prostatitis

open access: yesVIEW, EarlyView.
Immune checkpoint inhibitors (ICIs), an innovative class of cancer therapeutics, may elevate the risk of prostate inflammation (prostatitis) in a subset of male patients. Our investigation demonstrated that ICIs can induce inflammatory responses in prostate tissue; however, selectively targeting specific inflammatory pathways may potentially mitigate ...
Peng Luo   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy